ECONOMIC EVALUATION OF RITUXIMAB VERSUS AZATHIOPRINE FOR MAINTENANCE TREATMENT OF ANCA-ASSOCIATED VASCULITIS: THE MAINRITSAN TRIAL

被引：0
|
作者：
Montante, Annalisa [1 ]
Le Bras, Alicia [1 ]
Terrier, Benjamin [1 ]
Cohen, Pascal [1 ]
Puechal, Xavier [1 ]
Karras, Alexandre [1 ]
Ravaud, Philippe [1 ]
Guillevin, Loic [1 ]
Durand-Zaleski, Isabelle [1 ]
机构：
[1] French Vasculitis Study Grp, Paris, France
来源：
RHEUMATOLOGY | 2017年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
WS7_3
引用
收藏
页码：32 / 33
页数：2
相关论文
共 50 条
  • [31] Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis.
    Stone, John H.
    Merkel, Peter A.
    Spiera, Robert
    Seo, Philip
    Langford, Carol A.
    Hoffman, Gary S.
    Kallenberg, Cees G. M.
    Clair, E. William St.
    Turkiewicz, Anthony
    Tchao, Nadia K.
    Webber, Lisa
    Ding, Linna
    Sejismundo, Lourdes P.
    Mieras, Kathleen
    Weitzenkamp, David
    Ikle, David
    Seyfert-Margolis, Vicki
    Mueller, Mark
    Brunetta, Paul
    Allen, Nancy B.
    Fervenza, Fernando C.
    Geetha, Duvuru
    Keogh, Karina A.
    Kissin, Eugene Y.
    Monach, Paul A.
    Peikert, Tobias
    Stegeman, Coen
    Ytterberg, Steven R.
    Specks, Ulrich
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (03): : 221 - 232
  • [32] RITUXIMAB AS MAINTENANCE TREATMENT IN ANCA-ASSOCIATED VASCULITIS: SINGLE-CENTRE EXPERIENCE
    Hruskova, Zdenka
    Posova, Helena
    Bednarova, Vladimira
    Jancova, Eva
    Rysava, Romana
    Frausova, Doubravka
    Tesar, Vladimir
    RHEUMATOLOGY, 2017, 56 : 154 - 155
  • [33] Rituximab versus azathioprine for ANCA-associated vasculitis maintenance therapy: impact on global disability and health-related quality of life
    Pugnet, G.
    Pagnoux, C.
    Terrier, B.
    Perrodeau, E.
    Puechal, X.
    Karras, A.
    Khouatra, C.
    Aumaitre, O.
    Cohen, P.
    Maurier, F.
    Decaux, O.
    Ninet, J.
    Gobert, P.
    Quemeneur, T.
    Blanchard-Delaunay, C.
    Godmer, P.
    Carron, P. -L.
    Hatron, P. -Y.
    Limal, N.
    Hamidou, M.
    Ducret, M.
    Daugas, E.
    Papo, T.
    Bonnotte, B.
    Mahr, A.
    Ravaud, P.
    Mouthon, L.
    Guillevin, L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (03) : S54 - S59
  • [34] An international, open label, randomised controlled trial comparing rituximab with azathioprine as maintenance therapy in relapsing ANCA-associated vasculitis (RITAZAREM)
    Jayne, D.
    Smith, R.
    Merkel, P.
    PRESSE MEDICALE, 2013, 42 (04): : 768 - 768
  • [35] Impact of rituximab trials on the treatment of ANCA-associated vasculitis
    Alberici, Federico
    Jayne, David R. W.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (06) : 1151 - 1159
  • [36] Randomized trial of mycophenolate mofetil vs azathioprine for maintenance therapy in ANCA-associated vasculitis (IMPROVE)
    Hiemstra, Thomas
    Walsh, Michael
    De Groot, Kirsten
    Hauser, Thomas
    Mahr, Alfred
    Pagnoux, Christian
    Harper, Lorraine
    Savage, Caroline
    Tesar, Vladimir
    Neumann, Irmgard
    Wissing, Karl Martin
    Schmitt, Wilhelm
    Jayne, David
    APMIS, 2009, 117 : 77 - 78
  • [37] Rituximab Versus Cyclophosphamide for ANCA-Associated Vasculitis with Renal Involvement
    Geetha, Duvuru
    Specks, Ulrich
    Stone, John H.
    Merkel, Peter A.
    Seo, Philip
    Spiera, Robert
    Langford, Carol A.
    Hoffman, Gary S.
    Kallenberg, Cees G. M.
    St Clair, E. William
    Fessler, Barri J.
    Ding, Linna
    Tchao, Nadia K.
    Ikle, David
    Jepson, Brett
    Brunetta, Paul
    Fervenza, Fernando C.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 26 (04): : 976 - 985
  • [38] Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial
    Maritati, Federica
    Alberici, Federico
    Oliva, Elena
    Urban, Maria L.
    Palmisano, Alessandra
    Santarsia, Francesca
    Andrulli, Simeone
    Pavone, Laura
    Pesci, Alberto
    Grasselli, Chiara
    Santi, Rosaria
    Tumiati, Bruno
    Manenti, Lucio
    Buzio, Carlo
    Vaglio, Augusto
    PLOS ONE, 2017, 12 (10):
  • [39] Rituximab: effective in ANCA-associated vasculitis?
    Ulf Schönermarck
    Kirsten de Groot
    Nature Reviews Nephrology, 2011, 7 : 6 - 8
  • [40] Rituximab: effective in ANCA-associated vasculitis?
    Schoenermarck, Ulf
    de Groot, Kirsten
    NATURE REVIEWS NEPHROLOGY, 2011, 7 (01) : 6 - 8
12345